GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease ModelsJesse E. Hanson, Jorge J. Palop, Keran Ma et al.|Cell Reports|2020Cited by 91
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis TherapyJeffrey J. Jackson, Mikhail Zibinsky, Delia Bradford et al.|Journal of Medicinal Chemistry|2022Cited by 12